维普中文期刊产品整合服务
20篇 您的检索式:作者名="Yip A."
    题名 作者 年代 出处 被引量
1Non-functional Neuroendocrine Carcinoma of the Pancreas: Incidence, Tumor Biology, and Outcomes in 2,158 Patients显示文摘Jan Franko Wentao Feng Linwah Yip Elizabeth Genovese A. James Moser 2010Journal of Gastrointestinal Surgery2010,,3:4
2循环荷载作用下预制钢-混凝土混合连接件的有限元分析显示文摘提出一种用于钢-混凝土混合连接的非线性有限元分析方法。考虑了部分抗震设计的四个足尺钢-混连接点的详细的试验结果已在另一篇论文中予以讨论。然而,由于梁柱节点和试验构件特性的内在复杂性,试验研究是不够全面的。因此,提出了一种基于有限元模型和DIANA程序的分析方法。有限元模型通过新加坡南洋理工大学钢-混凝土混合连接的试验结果证实有效。对于影响节点性能的参数,如柱子的轴压力、连接板厚度、梁底部纵筋进行了研究。Sudhakar A. Kulkarni Woon Kwong Yip 2008钢结构2008,23,8:2
3The sticholysin family of pore-forming toxins induces the mixing of lipids in membrane domains显示文摘Uris Ros Michelle A. Edwards Raquel F. Epand Maria E. Lanio Shirley Schreier Christopher M. Yip Carlos Alvarez Richard M. Epand 2013BBA - Biomembranes2013,,11:1
4Normothermic Acellular Ex Vivo Liver Perfusion Reduces Liver and Bile Duct Injury of Pig Livers Retrieved After Cardiac Death显示文摘M. U. Boehnert J. C. Yeung F. Bazerbachi J. M. Knaak N. Selzner I. D. McGilvray O. D. Rotstein O. A. Adeyi S. M. Kandel P. Rogalla P. M. Yip G. A. Levy S. Keshavjee D. R. Grant M. Selzner 2013American Journal of Transplantation2013,,6:1
5Targeting of syndecan‐1 by microRNA miR‐10b promotes breast cancer cell motility and invasiveness via a Rho‐GTPase‐ and E‐cadherin‐dependent mechanism显示文摘Sherif A. Ibrahim George W. Yip Christian Stock Jun‐Wei Pan Claudia Neubauer Michaela Poeter Danute Pupjalis Chuay Yeng Koo Reinhard Kelsch Roland Schüle Ursula Rescher Ludwig Kiesel Martin G?tte 2012Int J Cancer2012,,6:1
6Tenofovir Monotherapy and Tenofovir Plus Entecavir Combination as Rescue Therapy for Entecavir Partial Responders显示文摘Benjamin Yip Kevin Chaung Carrie R. Wong Huy N. Trinh Huy A. Nguyen Aijaz Ahmed Ramsey Cheung Mindie H. Nguyen 2012Digestive Diseases and Sciences2012,,11:1
7Alcohol Activates the Hedgehog Pathway and Induces Related Procarcinogenic Processes in the Alcohol‐Preferring Rat Model of Hepatocarcinogenesis显示文摘Isaac S. Chan Cynthia D. Guy Mariana V. Machado Abigail Wank Vishnu Kadiyala Gregory Michelotti Steve Choi Marzena Swiderska‐Syn Gamze Karaca Thiago A. Pereira Michele T. Yip‐Schneider C. Max Schmidt Anna Mae Diehl 2014Alcohol Clin Exp Res2014,,3:1
8Enhanced recovery in the resection of colorectal liver metastases显示文摘Declan F. J. Dunne Vincent S. Yip Robert P. Jones Ewan A. McChesney Daniel T. Lythgoe Eftychia E. Psarelli Louise Jones Carmen Lacasia‐Purroy Hassan Z. Malik Graeme J. Poston Stephen W. Fenwick 2014J. Surg. Oncol2014,,2:1
9Circulating leukocyte TBET and GATA3 mRNA in patients with acute coronary syndrome显示文摘Timothy H. Rainer Rebecca W.Y. Chan Colin A. Graham Cangel P.Y. Chan Patrick C.F. Tan Gabriel W.K. Yip Cheuk-Man Yu 2012International Journal of Cardiology2012,,2:1
10Factors affecting estrogen receptor status in a multiracial Asian country: An analysis of 3557 cases显示文摘C.H. Yip N. Bhoo Pathy C.S. Uiterwaal N.A. Taib G.H. Tan K.S. Mun W.Y. Choo A. Rhodes 2011The Breast2011,,:1
11A combined OH/acetone planar laser-induced fluorescence imaging technique for visualizing combusting flows显示文摘B. Yip M. F. Miller A. Lozano R. K. Hanson 1994Experiments in Fluids1994,,5:1
12Acetone: a tracer for concentration measurements in gaseous flows by planar laser-induced fluorescence显示文摘A. Lozano B. Yip R. K. Hanson 1992Experiments in Fluids1992,,6:1
13Fine mapping of the 9q31 Hirschsprung’s disease locus显示文摘C. S. Tang Y. Sribudiani X. P. Miao A. R. Vries G. Burzynski M. T. So Y. Y. Leon B. H. Yip J. Osinga K. J. W. S. Hui J. B. G. M. Verheij S. S. Cherny P. K. H. Tam P. C. Sham R. M. W. Hofstra M. M. Garcia-Barceló 2010Human Genetics2010,,6:1
14A phase II study evaluating the tolerability and efficacy of CAELYX (liposomal doxorubicin, Doxil) in the treatment of unresectable pancreatic?carcinoma显示文摘S. Halford D. Yip C. S. Karapetis A. H. Strickland A. Steger H. T. Khawaja P. G. Harper 2001Annals of Oncology2001,,10:1
15Hepatitis B virus and hepatitis C virus interaction in Huh-7 cells显示文摘Nicholas S. Eyre Renee J. Phillips Scott Bowden Evelyn Yip Ben Dewar Stephen A. Locarnini Michael R. Beard 2009Journal of Hepatology2009,,3:1
16In Vitro Analysis of Transport and Metabolism of 4’-Thiothymidine in Human Tumor Cells显示文摘David A. Plotnik Stephen Wu Geoffrey R. Linn Franco Chi Tat Yip Natacha Lou Comandante Kenneth A. Krohn Jun Toyohara Jeffrey L. Schwartz 2014Nuclear Medicine and Biology2014,,:1
17Change in bone mineral density and its determinants in pre- and perimenopausal Chinese women: the Hong Kong perimenopausal women osteoporosis study显示文摘S. C. Ho S. G. Chan Y. B. Yip C. S. Y. Chan J. L. F. Woo A. Sham 2008Osteoporosis International2008,,12:1
18ClinicalexperiencewiththecordiscoronarystentintheChinesepopulation显示文摘ClinicalexperiencewiththecordiscoronarystentintheChinesepopulationK.Fan,W.H.Chow,L.Chow,A.YipandK.L.CheungObjectiveToasesthes...K. Fan W.H. Chow L. Chow A. Yip K.L. Cheung 1998Chinese Medical Journal1998,,4:0
19静脉注射吗啡和局部丁卡因治疗中线放置早产儿的疼痛显示文摘Context: There is limited evidence of the analgesic effectiveness of opioid analgesia or topical anesthesia during central line placement in neonates, and there are no previous studies of their relative effectiveness. Objective: To determine the effectiveness and safety of topical tetracaine, intravenous morphine, or tetracaine plus morphine for alleviating pain in ventilated neonates during central line placement. Design, Setting, and Participants: Randomized, double-blind, controlled trial enrolling 132 ventilated neonates (mean gestational age, 30.6 SD, 4.6 weeks at study entry) and conducted between October 2000 and July 2005 in 2 neonatal intensive care units in Toronto, Ontario. Interventions: Prior to central line insertion, neonates were randomly assigned to receive tetracaine (n=42), morphine (n=38), or both (n=31); a separate nonrandomized group of 21 neonates receiving neither tetracaine nor morphine was used as a control group. Main Outcome Measures: The primary outcome measure was a pain score for the proportion of time neonates displayed facial grimacing (brow bulge) during different phases of the procedure (skin preparation, needle puncture, and recovery). In randomized neonates, safety assessments included blood pressure, ventilatory support, and local skin reactions. Results: Compared with no treatment, pain scores were lower in the morphine and tetracaine-morphine groups during skin preparation (mean difference, -0.22; 95%confidence interval CI , -0.4 to -0.04; P=.02 and -0.29; 95%CI, -0.49 to -0.09; P=.01, respectively), and needle puncture (mean difference, -0.35; 95%CI, -0.57 to -0.13; P=.003 and -0.47; 95%CI, -0.71 to -0.24; P< .001, respectively), but pain scores did not differ statistically for tetracaine alone vs no treatment. Pain scores were lower for morphine and tetracaine-morphine vs tetracaine during the skin preparation phase and for tetracaine-morphine vs tetracaine during needle puncture. Compared with neonates without morphine, morphine-treated neonates required larger increases in ventilation rate in the first 12 hours (mean difference, 3.9/min; 95%CI, 1.3-6.5/min; P=.003). Local skin reactions occurred in 30%of neonates given tetracaine vs 0%for morphine (risk difference, 0.30; 95%CI, 0.19-0.41; P < .001). Conclusion: In this study of ventilated neonates undergoing central line placement, morphine and tetracaine plus morphine provided superior analgesia to tetracaine; however, morphine caused respiratory depression and tetracaine caused erythema.Taddio A. Lee C. Yip A. 郭俊 2006世界核心医学期刊文摘(神经病学分册)2006,2,6:0
20静脉用吗啡和局部用丁卡因治疗早产新生儿中心静脉穿刺时的疼痛显示文摘Context: There is limited evidence of the analgesic effectiveness of opioid analgesia or topical anesthesia during central line placement in neonates, and there are no previous studies of their relative effectiveness. Objective: To determine the effectiveness and safety of topical tetracaine, intravenous morphine, or tetracaine plus morphine for alleviating pain in ventilated neonates during central line placement. Design, Setting, and Participants: Randomized, double- blind, controlled trial enrolling 132 ventilated neonates (mean gestational age, 30.6 [SD, 4.6] weeks at study entry) and conducted between October 2000 and July 2005 in 2 neonatal intensive care units in Toronto, Ontario. Interventions: Prior to central line insertion, neonates were randomly assigned to receive tetracaine (n=42), morphine (n=38), or both (n=31); a separate nonrandomized group of 21 neonates receiving neither tetracaine nor morphine was used as a control group. Main Outcome Measures: The primary outcome measure was a pain score for the proportion of time neonates displayed facial grimacing (brow bulge) during different phases of the procedure (skin preparation, needle puncture, and recovery). In randomized neonates, safety assessments included blood pressure, ventilatory support, and local skin reactions. Results: Compared with no treatment, pain scores were lower in the morphine and tetracaine- morphine groups during skin preparation (mean difference,- 0.22; 95% confidence interval [CI],- 0.4 to- 0.04; P=.02 and - 0.29; 95% CI,- 0.49 to- 0.09; P=.01, respectively), and needle puncture (mean difference, - 0.35; 95% CI,- 0.57 to- 0.13; P=.003 and- 0.47; 95% CI,- 0.71 to- 0.24; P < .001, respectively), but pain scores did not differ statistically for tetracaine alone vs no treatment. Pain scores were lower for morphine and tetracaine- morphine vs tetracaine during the skin preparation phase and for tetracaine- morphine vs tetracaine during needle puncture. Compared with neonates without morphine, morphine- treated neonates required larger increases in ventilation rate in the first 12 hours (mean difference, 3.9/min; 95% CI, 1.3- 6.5/min; P=.003). Local skin reactions occurred in 30% of neonates given tetracaine vs 0% for morphine (risk difference, 0.30; 95% CI, 0.19- 0.41; P < .001). Conclusion: In this study of ventilated neonates undergoing central line placement, morphine and tetracaine plus morphine provided superior analgesia to tetracaine; however, morphine caused respiratory depression and tetracaine caused erythema.Taddio A Lee C Yip A A. Taddio 张旸(译) 2006世界核心医学期刊文摘(妇产科学分册)2006,2,6:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费